GlassScriptPhysician profile
Michael J Szostak
NPI 1033101704
$5,981.15
in general payments reported to CMS, 2019-2025
31 companies · $3,049 in 2025
The $3,049 reported for 2025 was more than what 87% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,016 · 2020: $470 · 2021: $107 · 2022: $25.61 · 2023: $639 · 2024: $674 · 2025: $3,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,411 · Consulting Fee: $1,500 · Travel and Lodging: $451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.11 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $450.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,519.57 | 2023-2025 | |
| Astellas Pharma US INC | $868.67 | 2019-2025 | Xtandi |
| Janssen Biotech, INC. | $688.99 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Dendreon Pharmaceuticals LLC | $434.29 | 2019-2025 | Provenge |
| Urogen Pharma, INC. | $265.21 | 2023-2024 | Jelmyto |
| Abbvie INC. | $256.63 | 2019-2025 | Botox |
| Bioprotect Medical, INC. | $254.90 | 2024-2025 | Bioprotect Balloon Implant System |
| Boston Scientific Corporation | $180.66 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $177.53 | 2019-2025 | |
| Medtronic, INC. | $170.53 | 2024 | Interstim |
| Ferring Pharmaceuticals INC. | $136.49 | 2020-2025 | Adstiladrin |
| Coloplast Corp | $118.52 | 2019-2020 | |
| Telix Pharmaceuticals | $115.38 | 2025 | Illuccix |
| Antares Pharma, INC. | $113.27 | 2019-2020 | |
| Endo USA, INC. | $112.08 | 2024 | Xiaflex |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $81.35 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $66.67 | 2025 | |
| Sun Pharmaceutical Industries INC. | $54.48 | 2019-2020 | |
| Accord Healthcare, INC. | $46.37 | 2023-2025 | |
| Tolmar Pharmaceuticals, INC. | $41.61 | 2019-2020 | |
| Neotract INC. | $41.04 | 2019 | |
| Genzyme Corporation | $35.32 | 2020 | |
| Allergan, INC. | $34.84 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $32.06 | 2025 | Lynparza |
| Endo Pharmaceuticals INC. | $22.99 | 2020 | |
| Merck Sharp & Dohme LLC | $22.06 | 2020 | |
| Avadel Specialty Pharmaceuticals, LLC | $21.00 | 2019 | |
| Immunitybio, INC. | $19.81 | 2025 | |
| Sumitomo Pharma America, INC. | $18.14 | 2025 | Gemtesa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $18.09 | 2019 | |
| Photocure INC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Szostak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.